HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has maintained a Buy rating on AngioDynamics (NASDAQ:ANGO) but has reduced the price target from $20 to $18.

January 08, 2024 | 11:33 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AngioDynamics' price target has been lowered from $20 to $18 by HC Wainwright & Co., although the Buy rating is maintained.
The reduction in price target may cause some concern among investors, potentially leading to a short-term negative sentiment. However, the maintenance of a Buy rating suggests that the analyst still sees long-term value in the stock, which could mitigate any negative impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100